Mahajan D, Miller C, Hirose K, McCullough A, Yerian L priligy reviews Although the mechanisms underlying resistance to existing agents are complex, preclinical studies suggest that selective estrogen receptor downregulators SERDs, molecules which eliminate ERО± expression, may have particular utility in the treatment of breast cancers that have progressed on tamoxifen and or aromatase inhibitors
